Selected research
Industry Growth & Trends
Global Primidone Industry Growth and Trends Forecast to 2032
Market perspective
The global Primidone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Primidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Primidone include Amneal Pharm, Anda Repository, Dr Reddys Laboratories, Hikma Intl Pharms, Impax Laboratories, Lannett, Mutual Pharmaceutical, Oxford Pharms and Valeant, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Primidone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Primidone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Primidone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Primidone.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Primidone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Primidone Market by Company
Amneal Pharm
Anda Repository
Dr Reddys Laboratories
Hikma Intl Pharms
Impax Laboratories
Lannett
Mutual Pharmaceutical
Oxford Pharms
Valeant
Valeant Pharmaceuticals International
Vintage Pharmaceuticals
Watson Labs
West Ward Pharmaceutical
Xcel Pharmaceuticals
Primidone Segment by Type
50mg
250mg
Primidone Segment by Application
Epilepsy
Psychiatric Disorders
Essential Tremor
Primidone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Primidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Primidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Primidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Primidone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Primidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg
- 250mg
Applications
- Epilepsy
- Psychiatric Disorders
- Essential Tremor
Companies covered
- Amneal Pharm
- Anda Repository
- Dr Reddys Laboratories
- Hikma Intl Pharms
- Impax Laboratories
- Lannett
- Mutual Pharmaceutical
- Oxford Pharms
- Valeant
- Valeant Pharmaceuticals International
- Vintage Pharmaceuticals
- Watson Labs
- West Ward Pharmaceutical
- Xcel Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Primidone Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Primidone Sales Estimates and Forecasts (2021-2032)
- 1.3 Primidone Market by Type
- 1.3.1 50mg
- 1.3.2 250mg
- 1.4 Global Primidone Market Size by Type
- 1.4.1 Global Primidone Market Size Overview by Type (2021-2032)
- 1.4.2 Global Primidone Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Primidone Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Primidone Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Primidone Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Primidone Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Primidone Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Primidone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Primidone Industry Trends
- 2.2 Primidone Industry Drivers
- 2.3 Primidone Industry Opportunities and Challenges
- 2.4 Primidone Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Primidone Revenue (2021-2026)
- 3.2 Global Top Players by Primidone Sales (2021-2026)
- 3.3 Global Top Players by Primidone Price (2021-2026)
- 3.4 Global Primidone Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Primidone Major Company Production Sites & Headquarters
- 3.6 Global Primidone Company, Product Type & Application
- 3.7 Global Primidone Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Primidone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Primidone Players Market Share by Revenue in 2025
- 3.8.3 2025 Primidone Tier 1, Tier 2, and Tier 3
4 Primidone Regional Status and Outlook
- 4.1 Global Primidone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Primidone Historic Market Size by Region
- 4.2.1 Global Primidone Sales in Volume by Region (2021-2026)
- 4.2.2 Global Primidone Sales in Value by Region (2021-2026)
- 4.2.3 Global Primidone Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Primidone Forecasted Market Size by Region
- 4.3.1 Global Primidone Sales in Volume by Region (2027-2032)
- 4.3.2 Global Primidone Sales in Value by Region (2027-2032)
- 4.3.3 Global Primidone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Primidone by Application
- 5.1 Primidone Market by Application
- 5.1.1 Epilepsy
- 5.1.2 Psychiatric Disorders
- 5.1.3 Essential Tremor
- 5.2 Global Primidone Market Size by Application
- 5.2.1 Global Primidone Market Size Overview by Application (2021-2032)
- 5.2.2 Global Primidone Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Primidone Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Primidone Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Primidone Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Primidone Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Primidone Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Primidone Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Amneal Pharm
- 6.1.1 Amneal Pharm Company Information
- 6.1.2 Amneal Pharm Business Overview
- 6.1.3 Amneal Pharm Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Amneal Pharm Primidone Product Portfolio
- 6.1.5 Amneal Pharm Recent Developments
- 6.2 Anda Repository
- 6.2.1 Anda Repository Company Information
- 6.2.2 Anda Repository Business Overview
- 6.2.3 Anda Repository Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Anda Repository Primidone Product Portfolio
- 6.2.5 Anda Repository Recent Developments
- 6.3 Dr Reddys Laboratories
- 6.3.1 Dr Reddys Laboratories Company Information
- 6.3.2 Dr Reddys Laboratories Business Overview
- 6.3.3 Dr Reddys Laboratories Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Dr Reddys Laboratories Primidone Product Portfolio
- 6.3.5 Dr Reddys Laboratories Recent Developments
- 6.4 Hikma Intl Pharms
- 6.4.1 Hikma Intl Pharms Company Information
- 6.4.2 Hikma Intl Pharms Business Overview
- 6.4.3 Hikma Intl Pharms Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Hikma Intl Pharms Primidone Product Portfolio
- 6.4.5 Hikma Intl Pharms Recent Developments
- 6.5 Impax Laboratories
- 6.5.1 Impax Laboratories Company Information
- 6.5.2 Impax Laboratories Business Overview
- 6.5.3 Impax Laboratories Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Impax Laboratories Primidone Product Portfolio
- 6.5.5 Impax Laboratories Recent Developments
- 6.6 Lannett
- 6.6.1 Lannett Company Information
- 6.6.2 Lannett Business Overview
- 6.6.3 Lannett Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Lannett Primidone Product Portfolio
- 6.6.5 Lannett Recent Developments
- 6.7 Mutual Pharmaceutical
- 6.7.1 Mutual Pharmaceutical Company Information
- 6.7.2 Mutual Pharmaceutical Business Overview
- 6.7.3 Mutual Pharmaceutical Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Mutual Pharmaceutical Primidone Product Portfolio
- 6.7.5 Mutual Pharmaceutical Recent Developments
- 6.8 Oxford Pharms
- 6.8.1 Oxford Pharms Company Information
- 6.8.2 Oxford Pharms Business Overview
- 6.8.3 Oxford Pharms Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Oxford Pharms Primidone Product Portfolio
- 6.8.5 Oxford Pharms Recent Developments
- 6.9 Valeant
- 6.9.1 Valeant Company Information
- 6.9.2 Valeant Business Overview
- 6.9.3 Valeant Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Valeant Primidone Product Portfolio
- 6.9.5 Valeant Recent Developments
- 6.10 Valeant Pharmaceuticals International
- 6.10.1 Valeant Pharmaceuticals International Company Information
- 6.10.2 Valeant Pharmaceuticals International Business Overview
- 6.10.3 Valeant Pharmaceuticals International Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Valeant Pharmaceuticals International Primidone Product Portfolio
- 6.10.5 Valeant Pharmaceuticals International Recent Developments
- 6.11 Vintage Pharmaceuticals
- 6.11.1 Vintage Pharmaceuticals Company Information
- 6.11.2 Vintage Pharmaceuticals Business Overview
- 6.11.3 Vintage Pharmaceuticals Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Vintage Pharmaceuticals Primidone Product Portfolio
- 6.11.5 Vintage Pharmaceuticals Recent Developments
- 6.12 Watson Labs
- 6.12.1 Watson Labs Company Information
- 6.12.2 Watson Labs Business Overview
- 6.12.3 Watson Labs Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Watson Labs Primidone Product Portfolio
- 6.12.5 Watson Labs Recent Developments
- 6.13 West Ward Pharmaceutical
- 6.13.1 West Ward Pharmaceutical Company Information
- 6.13.2 West Ward Pharmaceutical Business Overview
- 6.13.3 West Ward Pharmaceutical Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 West Ward Pharmaceutical Primidone Product Portfolio
- 6.13.5 West Ward Pharmaceutical Recent Developments
- 6.14 Xcel Pharmaceuticals
- 6.14.1 Xcel Pharmaceuticals Company Information
- 6.14.2 Xcel Pharmaceuticals Business Overview
- 6.14.3 Xcel Pharmaceuticals Primidone Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Xcel Pharmaceuticals Primidone Product Portfolio
- 6.14.5 Xcel Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Primidone Sales by Country
- 7.1.1 North America Primidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Primidone Sales by Country (2021-2026)
- 7.1.3 North America Primidone Sales Forecast by Country (2027-2032)
- 7.2 North America Primidone Market Size by Country
- 7.2.1 North America Primidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Primidone Market Size by Country (2021-2026)
- 7.2.3 North America Primidone Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Primidone Sales by Country
- 8.1.1 Europe Primidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Primidone Sales by Country (2021-2026)
- 8.1.3 Europe Primidone Sales Forecast by Country (2027-2032)
- 8.2 Europe Primidone Market Size by Country
- 8.2.1 Europe Primidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Primidone Market Size by Country (2021-2026)
- 8.2.3 Europe Primidone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Primidone Sales by Country
- 9.1.1 Asia-Pacific Primidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Primidone Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Primidone Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Primidone Market Size by Country
- 9.2.1 Asia-Pacific Primidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Primidone Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Primidone Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Primidone Sales by Country
- 10.1.1 South America Primidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Primidone Sales by Country (2021-2026)
- 10.1.3 South America Primidone Sales Forecast by Country (2027-2032)
- 10.2 South America Primidone Market Size by Country
- 10.2.1 South America Primidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Primidone Market Size by Country (2021-2026)
- 10.2.3 South America Primidone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Primidone Sales by Country
- 11.1.1 Middle East and Africa Primidone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Primidone Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Primidone Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Primidone Market Size by Country
- 11.2.1 Middle East and Africa Primidone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Primidone Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Primidone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Primidone Value Chain Analysis
- 12.1.1 Primidone Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Primidone Production Mode & Process
- 12.2 Primidone Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Primidone Distributors
- 12.2.3 Primidone Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst